Exhibit 107
Calculation of Filing Fee Table
S-1
(Form Type)
Kairos Pharma, Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | Security Type | | Security Class Title | | Fee Calculation Rule | | | Amount Registered(1) | | | Proposed Maximum Offering Price Per Unit | | | Maximum Aggregate Offering Price | | | Fee Rate | | | Amount of Registration Fee | |
Fees to Be Paid | | Equity | | Common Stock issuable upon exercise of the Pre-Funded Warrants | | | 457 | (g) | | | 2,500,000 | | | $ | 1.40 | (2) | | $ | 3,500,000 | | | | 0.0001531 | | | $ | 536 | |
Fees to Be Paid | | Equity | | Common Stock issuable upon exercise of the Common Warrants | | | 457 | (g) | | | 3,750,000 | | | $ | 1.40 | (3) | | $ | 5,250,000 | | | | 0.0001531 | | | $ | 804 | |
Fees to Be Paid | | Equity | | Common Stock issuable upon exercise of Placement Agent Warrants | | | 457 | (g) | | | 175,000 | | | $ | 1.40 | (3) | | $ | 245,000 | | | | 0.0001531 | | | $ | 38 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total Offering Amounts | | | | | | | | | | | | | | $ | 8,995,000 | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total Fees Previously Paid | | | | | | | | | | | | | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total Fee Offsets | | | | | | | | | | | | | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Net Fee Due | | | | | | | | | | | | | | | | | | | | | | $ | 1,378 | |
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, par value $0.001 per share (“Common Stock”), in connection with any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock. |
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(g) of the Securities Act. The proposed maximum offering price per share for the Common Stock underlying the Pre-Funded Warrants is calculated based on the sale price of the Pre-Funded Warrants plus the exercise price of the Pre-Funded Warrants. |
(3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(g) of the Securities Act. The proposed maximum offering price per share are calculated based on the exercise price of the Common Warrant and Placement Agent Warrant. |